HLA Restriction of Carbamazepine-Specific T-Cell Clones from an HLA-A*31:01-Positive Hypersensitive Patient
Maike Lichtenfels, John Farrell, Monday O Ogese, Catherine C Bell, Sidonia Eckle, James McCluskey, B Kevin Park, Ana Alfirevic, Dean J Naisbitt, Munir Pirmohamed
Chemical Research in Toxicology | AMER CHEMICAL SOC | Published : 2014
Awarded by European Union
Awarded by Medical Research Council
Awarded by National Institute for Health Research
Awarded by Epilepsy Research UK
This work was funded from the European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement number 238132 and the Centre for Drug Safety Science supported by the Medical Research Council (G0700654). M.P. is a NIHR Senior Investigator and is funded by the NHS Chair of Pharmacogenetics from the UK Department of Health.